![J. Michael Flinn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
J. Michael Flinn
Plus aucun poste en cours
93 ans
Health Technology
Profil
J.
Michael Flinn has been a Director of Access Pharmaceuticals, Inc. since 1983 and is a Director of Lonesome Dove Petroleum, Inc. He was Chairman of Access Pharmaceuticals Board from 2004 to 2006 and a Member of the Compensation Committee.
From 1970 to 2000, Mr. Flinn was an Investment Counselor and a Consultant of the Operations Group for United Asset Management.
He served as a Security Analyst in the area of healthcare and natural resources.
From 1970 to 1995, Mr. Flinn was Principal and Chairman of Sirach Capital Management, Inc.
Anciens postes connus de J. Michael Flinn
| Sociétés | Poste | Fin |
|---|---|---|
Lonesome Dove Petroleum, Inc. | Directeur/Membre du Conseil | 18/07/2019 |
| ABEONA THERAPEUTICS INC. | Président | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Lonesome Dove Petroleum, Inc. |
